Inhibitors of Akt activity

Details for Australian Patent Application No. 2006258124 (hide)

Owner Merck & Co., Inc.

Inventors Armstrong, Donna J.; Rossi, Michael A.; Kelly, Michael J. III; Rodzinak, Kevin J.; Hu, Essa H.; Li, Yiwei; Liang, Jun; Wang, Jiabing; Sanderson, Philip E.; Layton, Mark E.

Agent Spruson & Ferguson

Pub. Number AU-B-2006258124

PCT Pub. Number WO2006/135627

Priority 60/689,726 10.06.05 US; 60/734,188 07.11.05 US

Filing date 7 June 2006

Wipo publication date 21 December 2006

Acceptance publication date 3 September 2009

International Classifications

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

C07D 249/00 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

Event Publications

20 December 2007 PCT application entered the National Phase

  PCT publication WO2006/135627 Priority application(s): WO2006/135627

3 September 2009 Application Accepted

  Published as AU-B-2006258124

7 January 2010 Standard Patent Sealed

7 January 2010 Corrigenda

  Applications Accepted - Name Index Under the name Merck & Co., Inc., Application No. 2006258124, under INID (72), correct the co-inventor to read Kelly III, Michael J. Corrigenda

28 January 2010 Amendment Made

  The nature of the amendment is: Amend the patent name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006258126-Synergistic modulation of FLT3 kinase using alkylquinolines and alkylquinazolines

2006258117-Vapor phase hydrogen peroxide deodorizer